Thirteen lncRNAs (including KCNJ2-AS1) are selected as prognostic biomarkers, based on which a prognostic signature is constructed for predicting the disease free survival in gastric cancer patients (21). The gene discussed is KCNJ2; the disease is gastric cancer.